Angle - Overview

ANGLE is a world leading liquid biopsy company with sample to answer solutions. ANGLE’s proven patent protected platforms include an epitope-independent circulating tumor cell (CTC) harvesting technology and a downstream analysis system for cost effective, highly multiplexed analysis of nucleic acids and proteins.

Registrars:

Key Personnel

CEO: Andrew D Newland
Finance Director: Ian F Griffiths
Chairman: Jan Groen
Non-Executive Director: Juliet Thompson, Joseph (Joe) Eid M.D.
Senior Independent Director: Brian Howlett

Contact Details

Address: 10 Nugent Road, Surrey Research Park, Guildford, Surrey, United Kingdom
Phone: +44 (0)1483 343434
Fax:
Website: http://angleplc.com/
Email:

Listings

ISIN: GB0034330679
Sector: Support, Support
Main Indices: FTSE AIM All-Share